Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 5.956 | 7.276 | 7.236 | 6.477 | -18.468 | -16.255 | -6.53 | 4.925 |
Return on Equity (%) | 14.937 | 16.396 | 16.609 | 16.149 | -55.413 | -75.985 | -54.208 | 43.693 |
Return on Invested Capital (%) | 12.29 | 12.946 | 12.453 | 12.383 | -14.757 | -16.632 | -3.154 | 13.473 |
Operating Margin (%) | 25.194 | 29.993 | 31.483 | 29.336 | -329.407 | -426.268 | -13.667 | 32.974 |
Net Profit Margin (%) | 20.87 | 25.742 | 26.662 | 23.913 | -385.324 | -558.929 | -37.214 | 17.736 |
Book Value Per Share | 37.614 | 44.243 | 39.114 | 43.499 | 28.305 | 15.065 | 6.396 | 14.307 |
Earnings Per Share | 5.47 | 6.91 | 7.679 | 7.943 | -21.861 | -20.629 | -8.443 | 6.612 |
Cash Per Share | 0.565 | 0.511 | 1.221 | 1.03 | 13.893 | 10.595 | 7.578 | 1.936 |
Working Capital Per Share | -15.742 | -16.783 | -24.89 | -28.706 | -0.85 | -14.452 | -21.024 | -29.647 |
Operating Profit Per Share | 36.215 | 37.321 | 40.254 | 46.294 | 8.329 | 6.008 | 34.621 | 54.159 |
EBIT Per Share | 5.47 | 6.91 | 7.699 | 8.064 | -21.777 | -20.629 | -8.443 | 6.639 |
EBITDA Per Share | 5.47 | 6.91 | 7.699 | 8.064 | -21.777 | -20.629 | -8.443 | 6.639 |
Free Cash Flow Per Share | 12.812 | 5.92 | 19.569 | 16.302 | -19.219 | -16.895 | -3.339 | 16.197 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 234,61M | 235,2M | 235,85M | 236,55M | 265,2M | 255M | 255,35M | 256,65M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 255,35M | 255,74M | 256,17M | 256,24M | 256,65M | 257,35M | 285,86M | 297,34M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | 16.424 | N/A | N/A | N/A | 31.55 | N/A | N/A |
Net Profit Margin (%) | N/A | -2.526 | N/A | N/A | N/A | 14.162 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 64,97B |
Ratio cours/bénéfice | 38,67 |
Ratio prix/ventes | 4,72 |
Ratio prix/liquidités | 132,04 |
Ratio prix/valeur comptable | 13,39 |
Rendement de dividende | - |
Actions en circulation | 268,88M |
Volume moyen (1 semaine) | 1,71M |
Volume moyen (1 mois) | 1,76M |
Variation sur 52 semaines | 129,76% |
Plus haut sur 52 semaines | 245,91 |
Plus bas sur 52 semaines | 105,365 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales